Our history
2011 marked the beginning of a company inspired by the concept of "One Health”. Founded by veterinary oncologist Dominique Tierny, OCRvet emerged with the clear goal of moving beyond the conventional wisdom of medicine and introducing innovative approaches to animal health.
R&D assets evolution
2011
- Vet sites for comparative medicine
- Project selected and funded by the French Inter-Ministry Fund : Caninca
2011
2014-2019
- Comparative medicine in oncology for Pharma-Biotech (EU, US)
2014-2019
2016
- DogToMan project selected and funded by the French Inter-Ministry Fund
- European veterinary clinical network
- Labcom “O’Dreams”: OCR/PRISM (Inserm Univ Lille)
2016
2019
- Development of innovative tools to expand the canine model contribution in translational oncology : Eureka ICOM
2019
2021
- Project on canine mammary tumor : 3R INCa
- Development of a robot- assisted medical device for biopsy and brachytherapy of the prostate under MRI imaging control : CoBra
2021
2024
- Biomedical innovation for facial bone reconstruction in oncology : BIOFACE
2024
Service offering evolution
2011
- Creation of OCR – (Oncovet Clinical Research)
- Biobank
2011
2014-2019
- Development of a French veterinary clinical network
- Lille’s ONCOLILLE consortium labelled Integrated Cancer Research Site
2014-2019
2016
- Regulatory veterinary clinical trials
- Consulting services in innovative veterinary products development (scientific, regulatory)
- Histology / IHC preclinical
2016
2019
- In vivo / ex vivo canine trials
- Preclinical studies coordination
2019
2022
- Launch in Poland
- Recruitment of a veterinary clinical research assistant in Poland
2022
2023
- New services in Data Management
- Name changed to OCRvet
2023
2024
- Launch in Italy and Portugal
- New website
- Target for ISO 9001 label
2024